Rapid Micro Biosystems annual stock-based compensation
2020
2021
2022
2023
2024
2025
Rapid Micro Biosystems Stock-Based Compensation Growth & History (RPID)
Rapid Micro Biosystems's stock-based compensation was $4.0M for fiscal 2025.
View full Rapid Micro Biosystems company overviewRapid Micro Biosystems annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.0M | $159,000 | +4.10% |
| 2024 | 2024-12-31 | $3.9M | −$876,000 | −18.44% |
| 2023 | 2023-12-31 | $4.8M | $731,000 | +18.19% |
| 2022 | 2022-12-31 | $4.0M | $2.2M | +118.07% |
| 2021 | 2021-12-31 | $1.8M | $1.3M | +245.78% |
| 2020 | 2020-12-31 | $533,000 | — | — |
Rapid Micro Biosystems quarterly stock-based compensation
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.3M | $103,000 | +8.46% |
| Q1 2026 | 2026-03-31 | $1.2M | $181,000 | +17.37% |
| Q4 2025 | 2025-12-31 | $627,000 | −$62,000 | −9.00% |
| Q3 2025 | 2025-09-30 | $1.1M | $217,000 | +23.36% |
| Q2 2025 | 2025-06-30 | $1.2M | $47,000 | +4.01% |
| Q1 2025 | 2025-03-31 | $1.0M | −$43,000 | −3.96% |
| Q4 2024 | 2024-12-31 | $689,000 | −$333,000 | −32.58% |
| Q3 2024 | 2024-09-30 | $929,000 | −$322,000 | −25.74% |
| Q2 2024 | 2024-06-30 | $1.2M | −$63,000 | −5.11% |
| Q1 2024 | 2024-03-31 | $1.1M | −$158,000 | −12.71% |
| Q4 2023 | 2023-12-31 | $1.0M | −$83,000 | −7.51% |
| Q3 2023 | 2023-09-30 | $1.3M | $578,000 | +85.88% |
| Q2 2023 | 2023-06-30 | $1.2M | −$24,000 | −1.91% |
| Q1 2023 | 2023-03-31 | $1.2M | $260,000 | +26.45% |
| Q4 2022 | 2022-12-31 | $1.1M | $427,000 | +62.98% |
| Q3 2022 | 2022-09-30 | $673,000 | $89,000 | +15.24% |
| Q2 2022 | 2022-06-30 | $1.3M | $868,000 | +222.56% |
| Q1 2022 | 2022-03-31 | $983,000 | $792,000 | +414.66% |
| Q4 2021 | 2021-12-31 | $678,000 | — | — |
| Q3 2021 | 2021-09-30 | $584,000 | $469,000 | +407.83% |
| Q2 2021 | 2021-06-30 | $390,000 | $264,000 | +209.52% |
| Q1 2021 | 2021-03-31 | $191,000 | — | — |
| Q3 2020 | 2020-09-30 | $115,000 | — | — |
| Q2 2020 | 2020-06-30 | $126,000 | — | — |
Rapid Micro Biosystems stock-based compensation trends
Over the last five fiscal years, Rapid Micro Biosystems's stock-based compensation increased from $533,000 to $4.0M, a change of $3.5M. The latest reported quarter, Q2 2026, shows $1.3M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rapid Micro Biosystems source filings ↗